MAPK1 and cancer: RAS-RAF signaling to mitogen-activated protein kinases (MAP2K/MEK) and extracellular regulated kinases (ERK) is a core cancer pathway that regulates cell proliferation, survival, tumorigenesis, and chemoresistance [24,25,26,27,28].